CYTOKINETICS, INCORPORATED Stock-Based Compensation
CYTOKINETICS, INCORPORATED (CYTK) reported Stock-Based Compensation of $66.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $35.71M, a 29.69% increase year-over-year.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $30.39M, a 29.07% increase year-over-year.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $30.51M, a 16.21% increase year-over-year.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $30.70M, a 21.06% increase year-over-year.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for fiscal 2025 was $112.29M, a 14.76% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for fiscal 2024 was $97.84M, a 35.77% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for fiscal 2023 was $72.06M, a 50.60% increase from fiscal 2022.
- CYTOKINETICS, INCORPORATED share-based payment arrangement, noncash expense for fiscal 2022 was $47.85M, a 78.34% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 167 month | Share-based Payment Arrangement, Noncash Expense 170 month | Share-based Payment Arrangement, Noncash Expense 173 month | Share-based Payment Arrangement, Noncash Expense 176 month | Share-based Payment Arrangement, Noncash Expense 179 month | Share-based Payment Arrangement, Noncash Expense 182 month | Share-based Payment Arrangement, Noncash Expense 185 month | Share-based Payment Arrangement, Noncash Expense 188 month | Share-based Payment Arrangement, Noncash Expense 191 month | Share-based Payment Arrangement, Noncash Expense 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $66.11M 10-Q · filed 2026-08-06 | $96.61M derived: sum of 3 quarters · filed 2026-08-06 | $127.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2026-03-31 | $30.39M 10-Q · filed 2026-05-05 | $60.90M derived: sum of 2 quarters · filed 2026-05-05 | $91.60M derived: sum of 3 quarters · filed 2026-05-05 | $119.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-12-31 | $30.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.20M derived: sum of 2 quarters · filed 2026-02-26 | $88.74M derived: sum of 3 quarters · filed 2026-08-06 | $112.29M 10-K · filed 2026-02-26 | ||||||||||
| 2025-09-30 | $30.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $58.23M derived: sum of 2 quarters · filed 2026-08-06 | $81.78M 10-Q · filed 2025-11-05 | $108.03M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-06-30 | $27.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $51.08M 10-Q · filed 2026-08-06 | $77.33M derived: sum of 3 quarters · filed 2026-08-06 | $102.69M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||
| 2025-03-31 | $23.55M 10-Q · filed 2026-05-05 | $49.80M derived: sum of 2 quarters · filed 2026-05-05 | $75.16M derived: sum of 3 quarters · filed 2026-05-05 | $99.78M derived: sum of 4 quarters · filed 2026-05-05 | ||||||||||
| 2024-12-31 | $26.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $51.61M derived: sum of 2 quarters · filed 2026-02-26 | $76.23M derived: sum of 3 quarters · filed 2026-02-26 | $97.84M 10-K · filed 2026-02-26 | ||||||||||
| 2024-09-30 | $25.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $49.98M derived: sum of 2 quarters · filed 2025-11-05 | $71.59M 10-Q · filed 2025-11-05 | $91.08M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-06-30 | $24.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $46.23M 10-Q · filed 2025-08-07 | $65.72M derived: sum of 3 quarters · filed 2026-02-26 | $84.44M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2024-03-31 | $21.61M 10-Q · filed 2025-05-06 | $41.10M derived: sum of 2 quarters · filed 2026-02-26 | $59.81M derived: sum of 3 quarters · filed 2026-02-26 | $78.48M derived: sum of 4 quarters · filed 2026-02-26 | ||||||||||
| 2023-12-31 | $19.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.20M derived: sum of 2 quarters · filed 2026-02-26 | $56.87M derived: sum of 3 quarters · filed 2026-02-26 | $72.06M 10-K · filed 2026-02-26 | ||||||||||
| 2023-09-30 | $18.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $37.38M derived: sum of 2 quarters · filed 2024-11-07 | $52.58M 10-Q · filed 2024-11-07 | $66.08M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-06-30 | $18.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $33.86M 10-Q · filed 2024-08-09 | $47.36M derived: sum of 3 quarters · filed 2025-02-27 | $60.53M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2023-03-31 | $15.19M 10-Q · filed 2024-05-10 | $28.69M derived: sum of 2 quarters · filed 2025-02-27 | $41.87M derived: sum of 3 quarters · filed 2025-02-27 | $54.06M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||
| 2022-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $26.67M derived: sum of 2 quarters · filed 2025-02-27 | $38.87M derived: sum of 3 quarters · filed 2025-02-27 | $47.85M 10-K · filed 2025-02-27 | ||||||||||
| 2022-09-30 | $13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $25.37M derived: sum of 2 quarters · filed 2023-11-03 | $34.35M 10-Q · filed 2023-11-03 | $41.07M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-06-30 | $12.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $21.18M 10-Q · filed 2023-08-03 | $27.89M derived: sum of 3 quarters · filed 2024-02-28 | $35.66M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2022-03-31 | $8.98M 10-Q · filed 2023-05-05 | $15.70M derived: sum of 2 quarters · filed 2024-02-28 | $23.46M derived: sum of 3 quarters · filed 2024-02-28 | $30.56M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||
| 2021-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $14.48M derived: sum of 2 quarters · filed 2024-02-28 | $21.57M derived: sum of 3 quarters · filed 2024-02-28 | $26.83M 10-K · filed 2024-02-28 | ||||||||||
| 2021-09-30 | $7.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $14.86M derived: sum of 2 quarters · filed 2022-11-04 | $20.12M 10-Q · filed 2022-11-04 | $25.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $12.35M 10-Q · filed 2022-08-05 | $17.23M derived: sum of 3 quarters · filed 2023-03-01 | $21.92M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2021-03-31 | $5.26M 10-Q · filed 2022-05-06 | $10.14M derived: sum of 2 quarters · filed 2023-03-01 | $14.83M derived: sum of 3 quarters · filed 2023-03-01 | $19.36M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||
| 2020-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $9.57M derived: sum of 2 quarters · filed 2023-03-01 | $14.10M derived: sum of 3 quarters · filed 2023-03-01 | $17.62M 10-K · filed 2023-03-01 | ||||||||||
| 2020-09-30 | $4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $9.22M derived: sum of 2 quarters · filed 2021-11-05 | $12.74M 10-Q · filed 2021-11-05 | $15.62M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-06-30 | $4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $8.05M 10-Q · filed 2021-08-06 | $10.93M derived: sum of 3 quarters · filed 2022-02-25 | $13.71M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2020-03-31 | $3.52M 10-Q · filed 2021-05-07 | $6.40M derived: sum of 2 quarters · filed 2022-02-25 | $9.18M derived: sum of 3 quarters · filed 2022-02-25 | $12.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||||
| 2019-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.66M derived: sum of 2 quarters · filed 2022-02-25 | $8.48M derived: sum of 3 quarters · filed 2022-02-25 | $10.76M 10-K · filed 2022-02-25 | ||||||||||
| 2019-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $5.60M derived: sum of 2 quarters · filed 2020-11-06 | $7.88M 10-Q · filed 2020-11-06 | |||||||||||
| 2019-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $5.10M 10-Q · filed 2020-08-07 | ||||||||||||
| 2019-03-31 | $2.28M 10-Q · filed 2020-05-08 | |||||||||||||
| 2018-12-31 | $9.76M 10-K · filed 2021-02-26 | |||||||||||||
| 2017-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.89M derived: sum of 2 quarters · filed 2019-03-07 | $7.11M derived: sum of 3 quarters · filed 2019-03-07 | $9.03M 10-K · filed 2019-03-07 | ||||||||||
| 2017-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $4.67M derived: sum of 2 quarters · filed 2017-11-03 | $6.59M 10-Q · filed 2017-11-03 | $8.47M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2017-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $4.14M 10-Q · filed 2017-08-04 | $6.02M derived: sum of 3 quarters · filed 2018-03-05 | $7.89M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2017-03-31 | $1.92M 10-Q · filed 2017-05-04 | $3.80M derived: sum of 2 quarters · filed 2018-03-05 | $5.67M derived: sum of 3 quarters · filed 2018-03-05 | $7.46M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $3.75M derived: sum of 2 quarters · filed 2018-03-05 | $5.54M derived: sum of 3 quarters · filed 2018-03-05 | $7.15M 10-K · filed 2018-03-05 | ||||||||||
| 2016-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $3.65M derived: sum of 2 quarters · filed 2017-11-03 | $5.27M 10-Q · filed 2017-11-03 | $6.61M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $3.40M 10-Q · filed 2017-08-04 | $4.75M derived: sum of 3 quarters · filed 2018-03-05 | $5.87M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-03-31 | $1.61M 10-Q · filed 2017-05-04 | $2.96M derived: sum of 2 quarters · filed 2018-03-05 | $4.08M derived: sum of 3 quarters · filed 2018-03-05 | $5.28M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2015-12-31 | $1.35M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | $2.47M derived: sum of 2 quarters · filed 2018-03-05 | $3.67M derived: sum of 3 quarters · filed 2018-03-05 | $4.57M 10-K · filed 2018-03-05 | ||||||||||
| 2015-09-30 | $1.12M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-12-15 | $2.32M derived: sum of 2 quarters · filed 2016-12-15 | $3.22M 10-Q/A · filed 2016-12-15 | $4.11M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.10M 10-Q · filed 2016-08-04 | $2.98M derived: sum of 3 quarters · filed 2017-03-06 | $3.88M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-03-31 | $896.00K 10-Q · filed 2016-05-05 | $1.78M derived: sum of 2 quarters · filed 2017-03-06 | $2.67M derived: sum of 3 quarters · filed 2017-03-06 | $3.53M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2014-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.78M derived: sum of 2 quarters · filed 2017-03-06 | $2.64M derived: sum of 3 quarters · filed 2017-03-06 | $3.33M 10-K · filed 2017-03-06 | ||||||||||
| 2014-09-30 | $891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.75M derived: sum of 2 quarters · filed 2015-11-05 | $2.44M 10-Q · filed 2015-11-05 | $3.10M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $859.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $1.55M 10-Q · filed 2015-08-05 | $2.21M derived: sum of 3 quarters · filed 2016-03-03 | $3.05M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $694.00K 10-Q · filed 2015-05-04 | $1.35M derived: sum of 2 quarters · filed 2016-03-03 | $2.19M derived: sum of 3 quarters · filed 2016-03-03 | $3.33M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2013-12-31 | $656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.50M derived: sum of 2 quarters · filed 2016-03-03 | $2.63M derived: sum of 3 quarters · filed 2016-03-03 | $3.60M 10-K · filed 2016-03-03 | ||||||||||
| 2013-09-30 | $845.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.98M derived: sum of 2 quarters · filed 2014-11-06 | $2.94M 10-Q · filed 2014-11-06 | $3.85M derived: sum of 4 quarters · filed 2015-03-06 | $39.07M 10-Q · filed 2013-11-06 | |||||||||
| 2013-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.10M 10-Q · filed 2014-08-07 | $3.00M derived: sum of 3 quarters · filed 2015-03-06 | $4.07M derived: sum of 4 quarters · filed 2015-03-06 | $38.22M 10-Q · filed 2013-08-07 | |||||||||
| 2013-03-31 | $966.00K 10-Q · filed 2014-05-07 | $1.87M derived: sum of 2 quarters · filed 2015-03-06 | $2.94M derived: sum of 3 quarters · filed 2015-03-06 | $3.81M derived: sum of 4 quarters · filed 2015-03-06 | $37.09M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $1.97M derived: sum of 2 quarters · filed 2015-03-06 | $2.84M derived: sum of 3 quarters · filed 2015-03-06 | $3.78M 10-K · filed 2015-03-06 | $36.13M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.93M derived: sum of 2 quarters · filed 2013-11-06 | $2.88M 10-Q · filed 2013-11-06 | $3.72M derived: sum of 4 quarters · filed 2014-03-07 | $35.22M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | $869.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $1.81M 10-Q · filed 2013-08-07 | $2.65M derived: sum of 3 quarters · filed 2014-03-07 | $3.39M derived: sum of 4 quarters · filed 2014-03-07 | $34.16M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | $943.00K 10-Q · filed 2013-05-08 | $1.78M derived: sum of 2 quarters · filed 2014-03-07 | $2.52M derived: sum of 3 quarters · filed 2014-03-07 | $3.25M derived: sum of 4 quarters · filed 2014-03-07 | $33.29M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.58M derived: sum of 2 quarters · filed 2014-03-07 | $2.31M derived: sum of 3 quarters · filed 2014-03-07 | $3.07M 10-K · filed 2014-03-07 | $32.34M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | $736.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $1.47M derived: sum of 2 quarters · filed 2012-11-07 | $2.23M 10-Q · filed 2012-11-07 | $3.08M derived: sum of 4 quarters · filed 2013-03-15 | $31.50M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | $731.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $1.49M 10-Q · filed 2012-08-06 | $2.34M derived: sum of 3 quarters · filed 2013-03-15 | $3.50M derived: sum of 4 quarters · filed 2013-03-15 | $30.77M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | $761.00K 10-Q · filed 2012-05-04 | $1.61M derived: sum of 2 quarters · filed 2013-03-15 | $2.77M derived: sum of 3 quarters · filed 2013-03-15 | |||||||||||
| 2010-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $2.01M derived: sum of 2 quarters · filed 2013-03-15 | $4.02M 10-K · filed 2013-03-15 | |||||||||||
| 2010-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $3.17M 10-Q · filed 2011-11-04 | ||||||||||||
| 2010-06-30 | $2.01M 10-Q · filed 2011-08-04 | |||||||||||||
| 2009-12-31 | $4.91M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |